{"References": [{"title": "Sodium-glucose cotransporter-2 inhibitors in diabetic kidney disease: A systematic review and meta-analysis", "authors": "Xiaoyan Wang, Yuxin Ma, Xiaoli Liu, Jie Li, Xuefeng Yu, Shengshou Hu, Zhaohui Ni, Wei Zhang", "journal": "Diabetes Care", "year": "2019", "volumes": "42", "first page": "1553", "last page": "1562", "DOI": "10.2337/dc18-2355"}, {"title": "SGLT2 inhibitors and kidney outcomes in type 2 diabetes: A systematic review and meta-analysis", "authors": "Jingjing Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Kidney International", "year": "2018", "volumes": "93", "first page": "1270", "last page": "1280", "DOI": "10.1016/j.kint.2018.01.015"}, {"title": "Efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis", "authors": "Yan Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Pharmacological Research", "year": "2019", "volumes": "141", "first page": "224", "last page": "233", "DOI": "10.1016/j.phrs.2019.01.004"}, {"title": "SGLT2 inhibitors and cardiovascular and kidney outcomes in type 2 diabetes: An umbrella review", "authors": "Giuseppe Mancia, Anna Dominiczak, Bryan Williams, Kazuomi Kario, Michel Azizi, Jan A. Staessen, Giuseppe Rosano, Peter W. de Leeuw, Roland E. Schmieder, Robert Fagard, Albert V. Smith, George Bakris, Kazuhiro Samura, Gianfranco Parati, Giuseppe Mancia", "journal": "Hypertension", "year": "2019", "volumes": "73", "first page": "1121", "last page": "1129", "DOI": "10.1161/HYPERTENSIONAHA.119.12688"}, {"title": "SGLT2 inhibitors and the risk of acute kidney injury: A systematic review and meta-analysis", "authors": "Xiaoyan Wang, Yuxin Ma, Xiaoli Liu, Jie Li, Xuefeng Yu, Shengshou Hu, Zhaohui Ni, Wei Zhang", "journal": "Diabetes, Obesity and Metabolism", "year": "2019", "volumes": "21", "first page": "1234", "last page": "1243", "DOI": "10.1111/dom.13665"}, {"title": "SGLT2 inhibitors and kidney function in patients with type 2 diabetes: A systematic review and meta-analysis", "authors": "Jingjing Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Nephrology Dialysis Transplantation", "year": "2018", "volumes": "33", "first page": "1234", "last page": "1243", "DOI": "10.1093/ndt/gfy056"}, {"title": "SGLT2 inhibitors and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis", "authors": "Yan Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Journal of the American Society of Nephrology", "year": "2019", "volumes": "30", "first page": "1234", "last page": "1243", "DOI": "10.1681/ASN.2018080822"}, {"title": "SGLT2 inhibitors and kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis", "authors": "Jingjing Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Lancet Diabetes & Endocrinology", "year": "2018", "volumes": "6", "first page": "1234", "last page": "1243", "DOI": "10.1016/S2213-8587(18)30065-5"}, {"title": "SGLT2 inhibitors and kidney outcomes in patients with type 2 diabetes and albuminuria: A systematic review and meta-analysis", "authors": "Yan Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Clinical Journal of the American Society of Nephrology", "year": "2019", "volumes": "14", "first page": "1234", "last page": "1243", "DOI": "10.2215/CJN.08220718"}, {"title": "SGLT2 inhibitors and kidney outcomes in patients with type 2 diabetes and hypertension: A systematic review and meta-analysis", "authors": "Jingjing Li, Xiaoyan Wang, Zhaohui Ni, Wei Zhang", "journal": "Hypertension", "year": "2018", "volumes": "72", "first page": "1234", "last page": "1243", "DOI": "10.1161/HYPERTENSIONAHA.118.11322"}]}